Yihong Ren
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Yihong Ren has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Nan Su
Department of Epidemiology, School of Public Health, China Medical University, Shenyang 110122, China
1 shared publication - Sixuan Li
Institute for Nanobiotechnology, Johns Hopkins University, Baltimore, MD, USA
1 shared publication - Yanan Shan
Department of Epidemiology, School of Public Health, China Medical University, Shenyang 110122, China
1 shared publication - Yuxin Zhao
Department of Epidemiology, School of Public Health, China Medical University, Shenyang 110122, China
1 shared publication - Zhigang Cui
School of Nursing, China Medical University, Shenyang 110122, PR China
1 shared publication - Zhihua Yin
Department of Epidemiology, School of Public Health, China Medical University, Shenyang, People’s Republic of China
1 shared publication
Latest Publications
- Open Access
- 26 August 2023
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (17) , 13237
Circular RNA hsa_circ_0049657 as a Potential Biomarker in Non-Small Cell Lung Cancer
Non-small cell lung cancer (NSCLC) is a common lung disorder. In this study, we applied bioinformatics methods to analyze and investigate the role of the NFIX gene in NSCLC. Hsa_circ_0049657 is derived from the NFIX gene, this research aimed to verify the potential role of hsa_circ_0049657 in the development of NSCLC. The results suggested that NFIX was downregulated in most cancers. In addition, the NFIX expression in lung adenocarcinoma (LUAD) was associated with the clinicopathological stage. In LUAD, NFIX expression was associated with the degree of infiltration of most immune cells. The expression levels of hsa_circ_0049657 were significantly lower in cancerous tissues than in paracancerous tissues. Moreover, the results showed that hsa_circ_0049657 expression was downregulated in NSCLC cells. After overexpression of hsa_circ_0049657, the proliferation and migration ability of NSCLC cells were significantly inhibited and the level of apoptosis was increased. We could suppress the proliferation and invasion abilities and promote apoptosis of NSCLC cells by up-regulating hsa_circ_0049657, which might be a potential biomarker for NSCLC.
- 26 August 2023
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (17) , 13237
Open AccessCircular RNA hsa_circ_0049657 as a Potential Biomarker in Non-Small Cell Lung Cancer
Non-small cell lung cancer (NSCLC) is a common lung disorder. In this study, we applied bioinformatics methods to analyze and investigate the role of the NFIX gene in NSCLC. Hsa_circ_0049657 is derived from the NFIX gene, this research aimed to verify the potential role of hsa_circ_0049657 in the development of NSCLC. The results suggested that NFIX was downregulated in most cancers. In addition, the NFIX expression in lung adenocarcinoma (LUAD) was associated with the clinicopathological stage. In LUAD, NFIX expression was associated with the degree of infiltration of most immune cells. The expression levels of hsa_circ_0049657 were significantly lower in cancerous tissues than in paracancerous tissues. Moreover, the results showed that hsa_circ_0049657 expression was downregulated in NSCLC cells. After overexpression of hsa_circ_0049657, the proliferation and migration ability of NSCLC cells were significantly inhibited and the level of apoptosis was increased. We could suppress the proliferation and invasion abilities and promote apoptosis of NSCLC cells by up-regulating hsa_circ_0049657, which might be a potential biomarker for NSCLC.